Methods Of T-Lymphocyte Expansion
AssigneeCambridge Enterprise Limited
InventorsRandall Scott JOHNSON, Dr. Asis PALAZON, Petros Andreas TYRAKIS
Life of this patent
Estimating the term…
Loading patent…
AssigneeCambridge Enterprise Limited
InventorsRandall Scott JOHNSON, Dr. Asis PALAZON, Petros Andreas TYRAKIS
Estimating the term…
This invention relates to methods for the expansion of T-lymphocytes with a memory-like phenotype in which the intracellular concentration of a memory induction compound, such as 2-hydroxyglutarate (2HG), is increased in order to facilitate the maintenance of a memory-like phenotype. This may be useful for example, in cellular immunotherapy. The memory induction compound may the formula (I) wherein: p is 0 or 1, and when p is 0, Y is —CH2— or —C═, and when p is 1, Y is selected from —CH—, CH2, —NH—, —S, and -0-; —R1 is —H, —(CH2)nCH3, —(CH2)nCH2CO2H, —CH2Ph or —CH2PhOCH2Ph; and when Y is —CH—, CH2, —NH—, —S, or —O—, X is a single bonded group selected from —H, —OH, —NH2, —SH, —(CH2)nCH3 —(CH2)nCH2CO2H, —F, —Cl, —Br, and —I, or a double bonded group selected from ═O and ═S; and when Y is a double bonded —C═, X is —H; and each n is independently 0 to 12.
A method of expanding a population of memory-like T-lymphocytes comprising;
-4. (canceled)
(canceled)
(canceled)
-17. (canceled)
-24. (canceled)
-28. (canceled)
-33. (canceled)
(canceled)
(canceled)
-43. (canceled)
(canceled)
(canceled)
A method of treatment of a disease that is ameliorated by a T-lymphocyte mediated immune response comprising;
-50. (canceled)
-61. (canceled)
Dependencies are inferred from the claim text.